Connect Biopharma Holdings CNTB
NASDAQ CNTB
$0.76 -0.04 (-4.51%)
At close: Oct 22, 2026 · 4:00 PM EDT

Connect Biopharma Holdings (CNTB) Net Margin (2024 - 2026)

Updated

Connect Biopharma Holdings' Net Margin came in at -624.42% for Q2 2026, up 26248.49 percentage points from -26872.92% a year earlier and up 10853.68 percentage points from the prior quarter.

Analysis

Connect Biopharma Holdings (CNTB) Net Margin (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Connect Biopharma Holdings reported Net Margin of -2336.30%, down 48.62 percentage points year-over-year; for FY2025, it was -86687.50%, down 86627.47 percentage points from FY2024.

  • Going back by year, Net Margin was -60.03% in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 0.83%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 21.27%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -8.04%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 22.65%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 16.30%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 23.62%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -134.51%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -1.65%
10 Connect Biopharma Holdings 47.02 Mn -129.66 Mn - -624.42%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -624.42%
Mar 31, 2026 -11,478.11%
Sep 30, 2025 -107,500.00%
Jun 30, 2025 -26,872.92%
Dec 31, 2024 -1,275.93%
Sep 30, 2024 -1,056.28%
API Access

Connect Biopharma Holdings Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=CNTB&period=max&api_key=YOUR_API_KEY